Russell Investments Group
PDSB icon

Russell Investments Group’s PDS Biotechnology PDSB Stock Holding History

Russell Investments Group’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-109
Closed -$550 – 3284
2023
Q3 		$550 Buy
+109
New +$597 ﹤0.01% 3393
2017
Q4 		– Sell
-598
Closed -$128K – 2995
2017
Q3 		$128K Hold
598
– – ﹤0.01% 2743
2017
Q2 		$123K Buy
598
+87
+17% +$17.1K ﹤0.01% 2777
2017
Q1 		$93K Buy
+511
New +$101K ﹤0.01% 2822

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Russell Investments Group's PDSB Position: Q4 2023 in Review

Russell Investments Group sold out of PDS Biotechnology (PDSB) in Q4 2023, closing a stake of 109 shares — an estimated $550 sold.

Russell Investments Group first reported a position in PDSB in Q1 2017 and held it in 4 quarters. The position peaked at $128K in Q3 2017. 77 funds tracked by Wall St. Rank hold PDSB as of Q4 2023.

  • Russell Investments Group reported no remaining PDS Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Russell Investments Group sold 109 PDS Biotechnology shares in Q4 2023, an estimated $550.
  • Russell Investments Group first reported a position in PDS Biotechnology in Q1 2017 and held it in 4 quarters.
  • Russell Investments Group's PDS Biotechnology position peaked at $128K in Q3 2017.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2023.

Based on Russell Investments Group's 13F filing for Q4 2023, filed 5 Feb 2024.